CompletedPhase 4

Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

Thailand172 participantsStarted 2004-07

Plain-language summary

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

Who can participate

Age range7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who were diagnosed with EKC at the outpatient ophthalmic unit Exclusion Criteria: * children younger than six years * women being pregnant or during lactation * history of allergy to povidone-iodine * prior ocular surgery * contact lens usage and chronic eye diseases with current eye medications.

What they're measuring

the recovery rate within one week of treatment

Timeframe: 1 week

Trial details

NCT IDNCT01179412

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Viral Conjunctivitis trials